Current Molecular Targets Of Heterocyclic Compounds For Cancer Therapy
Download Current Molecular Targets Of Heterocyclic Compounds For Cancer Therapy full books in PDF, epub, and Kindle. Read online free Current Molecular Targets Of Heterocyclic Compounds For Cancer Therapy ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads.
Author |
: Vivek Asati |
Publisher |
: Elsevier |
Total Pages |
: 504 |
Release |
: 2024-04-10 |
ISBN-10 |
: 9780323996327 |
ISBN-13 |
: 0323996329 |
Rating |
: 4/5 (27 Downloads) |
Synopsis Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy by : Vivek Asati
Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy discusses recently developed treatments based on molecular targets which are genetically altered in cancer cells and are essential for tumor development and survival. Considerable research effort has been devoted to the development of targeted drugs that inhibit the action of pathogenic kinases, and clinical studies performed so far have validated the positive effects of kinase inhibitors for cancer treatment. Each chapter discusses a molecular target, such as ALK2, ATR, CK, Src-Abl, EGFR, Fyn-Blk-Lyn, IGFs, and PAK1. The book's chapters are written by experts who actively work on the targets to help readers fully understand how they can be used. This is a valuable resource for cancer researchers, oncologists, graduate students and members of the biomedical field who are interested in the potential of novel cancer therapies based on molecular targets. - Discusses recently discovered molecular targets for cancer therapy - Brings updated literature of heterocyclic compounds, an important construction motif for the development of new anticancer drugs - Encompasses comprehensive compilation of recently introduced anticancer drugs in the market and their health outcomes and pharmacoeconomics
Author |
: Bimal Krishna Banik |
Publisher |
: Walter de Gruyter GmbH & Co KG |
Total Pages |
: 532 |
Release |
: 2022-06-21 |
ISBN-10 |
: 9783110735772 |
ISBN-13 |
: 3110735776 |
Rating |
: 4/5 (72 Downloads) |
Synopsis Heterocyclic Anticancer Agents by : Bimal Krishna Banik
Cancer is an incredibly diverse and difficult disease to treat, and even after decades of research there is no definitive cure. Therefore, it is highly crucial to search for novel and new organic molecules with high potency, low toxicity, and low mutagenicity with selective anticancer properties that are able to overcome frequently developed resistance to available drugs. Heterocyclic anticancer agents are an important class of drugs for cancer therapies. This book explores different heterocycles and their use as anticancer therapies. Topics covered include different heterocyclic derivatives, the impact of heterocycles on anticancer agent development, and naturally occurring heterocycles.
Author |
: Rajesh Kumar Singh |
Publisher |
: Bentham Science Publishers |
Total Pages |
: 231 |
Release |
: 2022-09-02 |
ISBN-10 |
: 9789815040050 |
ISBN-13 |
: 9815040057 |
Rating |
: 4/5 (50 Downloads) |
Synopsis Key Heterocyclic Cores for Smart Anticancer Drug–Design Part II by : Rajesh Kumar Singh
This book provides an update on heterocyclic compounds that serve as key components of anti-cancer agents administered in pre-clinical settings. Many of the compounds highlighted in the book are being actively investigated for the bioactive properties against a range of cancer cell lines. There is potential for heterocyclic compounds to design agents that can target specific molecules to treat different types of cancers. Chapters are contributed by experts in pharmaceutical chemistry and are written to give a general overview of the topic to readers involved in all levels of research and decision-making in pharmaceutical chemistry and anti-cancer drug design. Part 2 of the book set covers these topics: - Anticancer targets for heterocyclic lead compounds - Coumarin hybrids for cancer treatments - Progress in nitrogen and sulphur-based heterocyclic compounds for their anticancer activity - Imidazole as an anticancer heterocyclic ring - Morpholine for profiling anticancer lead compounds - Natural products as anticancer agents
Author |
: Rajesh Kumar Singh |
Publisher |
: Bentham Science Publishers |
Total Pages |
: 285 |
Release |
: 2022-07-05 |
ISBN-10 |
: 9789815040081 |
ISBN-13 |
: 9815040081 |
Rating |
: 4/5 (81 Downloads) |
Synopsis Key Heterocyclic Cores for Smart Anticancer Drug–Design Part I by : Rajesh Kumar Singh
This book provides an update on heterocyclic compounds that serve as key components of anti-cancer agents administered in pre-clinical settings. Many of the compounds highlighted in the book are being actively investigated for the bioactive properties against a range of cancer cell lines. There is potential for heterocyclic compounds to design agents that can target specific molecules to treat different types of cancers. Chapters are contributed by experts in pharmaceutical chemistry and are written to give a general overview of the topic to readers involved in all levels of research and decision-making in pharmaceutical chemistry and anti-cancer drug design. Part 1 of the book set covers these topics: - Heterocyclic anticancer compounds derived from natural sources with their mechanism of action - The role of terpenoids as anticancer compounds: an insight into prevention and treatment - Recent advances in synthesis and anticancer activity of benzothiazole hybrids as anticancer agents - Structure-activity relationship studies of novel hybrid quinoline and quinolone derivatives as anticancer agents - Tetrazoles: structure and activity relationship as anticancer agents - Progress in nitrogen and oxygen-based heterocyclic compounds for their anticancer activity: an update (2017-2020)
Author |
: |
Publisher |
: |
Total Pages |
: 644 |
Release |
: 2011-04-11 |
ISBN-10 |
: 1441905081 |
ISBN-13 |
: 9781441905086 |
Rating |
: 4/5 (81 Downloads) |
Synopsis Macromolecular Anticancer Therapeutics by :
Author |
: Ankur Vaidya |
Publisher |
: Elsevier |
Total Pages |
: 266 |
Release |
: 2024-08-10 |
ISBN-10 |
: 9780443156458 |
ISBN-13 |
: 044315645X |
Rating |
: 4/5 (58 Downloads) |
Synopsis Caspases as Molecular Targets for Cancer Therapy by : Ankur Vaidya
Caspases as Molecular Targets for Cancer Therapy discusses the recent developments on targeted therapies for cancer using caspases. It describes the selection of specific caspases for cancer therapy with the current standard of care and highlights numerous assay techniques for caspase activities. This book discusses topics such as mutations within apoptosis gene, inflammatory caspases, tumor suppression, and the different caspase types and their role in anticancer activity. In addition, it discusses caspase activity assay procedure and future perspectives. It is a valuable resource for researchers, students, and members of biomedical and medical fields who want to learn more about novel anticancer targeted therapies. - Discusses thoroughly caspases, their mechanism of action, and mutations responsible for the development of cancer. - Presents updated literature of synthetic compounds for the development of caspase-mediated new anticancer drugs. - Encompasses comprehensive compilation of recently introduced anticancer drugs in the market, the health outcomes, and pharmacoeconomics.
Author |
: Friedemann Honecker |
Publisher |
: MDPI |
Total Pages |
: 119 |
Release |
: 2018-06-26 |
ISBN-10 |
: 9783038427650 |
ISBN-13 |
: 3038427659 |
Rating |
: 4/5 (50 Downloads) |
Synopsis Marine Compounds and Cancer by : Friedemann Honecker
This book is a printed edition of the Special Issue "Marine Compounds and Cancer" that was published in Marine Drugs
Author |
: Anne Le |
Publisher |
: Springer |
Total Pages |
: 186 |
Release |
: 2018-06-26 |
ISBN-10 |
: 9783319777368 |
ISBN-13 |
: 331977736X |
Rating |
: 4/5 (68 Downloads) |
Synopsis The Heterogeneity of Cancer Metabolism by : Anne Le
Genetic alterations in cancer, in addition to being the fundamental drivers of tumorigenesis, can give rise to a variety of metabolic adaptations that allow cancer cells to survive and proliferate in diverse tumor microenvironments. This metabolic flexibility is different from normal cellular metabolic processes and leads to heterogeneity in cancer metabolism within the same cancer type or even within the same tumor. In this book, we delve into the complexity and diversity of cancer metabolism, and highlight how understanding the heterogeneity of cancer metabolism is fundamental to the development of effective metabolism-based therapeutic strategies. Deciphering how cancer cells utilize various nutrient resources will enable clinicians and researchers to pair specific chemotherapeutic agents with patients who are most likely to respond with positive outcomes, allowing for more cost-effective and personalized cancer therapeutic strategies.
Author |
: Qiao-Hong Chen |
Publisher |
: MDPI |
Total Pages |
: 606 |
Release |
: 2021-03-02 |
ISBN-10 |
: 9783036501406 |
ISBN-13 |
: 3036501401 |
Rating |
: 4/5 (06 Downloads) |
Synopsis Anticancer Agents by : Qiao-Hong Chen
This book is a printed edition of the Special Issue entitled “Anticancer Agents: Design, Synthesis and Evaluation” that was published in Molecules. Two review articles and thirty research papers are included in the Special Issue. Three second-generation androgen receptor antagonists that have been approved by the U.S. FDA for the treatment of prostate cancer have been reviewed. Identification of mimics of protein partners as protein-protein interaction inhibitors via virtual screening has been summarized and discussed. Anticancer agents targeting various protein targets, including IGF-1R, Src, protein kinase, aromatase, HDAC, PARP, Toll-Like receptor, c-Met, PI3Kdelta, topoisomerase II, p53, and indoleamine 2,3-dioxygenase, have been explored. The analogs of three well-known tubulin-interacting natural products, paclitaxel, zampanolide, and colchicine, have been designed, synthesized, and evaluated. Several anticancer agents representing diverse chemical scaffolds were assessed in different kinds of cancer cell models. The capability of some anticancer agents to overcome the resistance to currently available drugs was also studied. In addition to looking into the in vitro ability of the anticancer agents to inhibit cancer cell proliferation, apoptosis, and cell cycle, in vivo antitumor efficacy in animal models and DFT were also investigated in some papers.
Author |
: Kulmira Nurgali |
Publisher |
: Frontiers Media SA |
Total Pages |
: 245 |
Release |
: 2018-06-12 |
ISBN-10 |
: 9782889454822 |
ISBN-13 |
: 2889454827 |
Rating |
: 4/5 (22 Downloads) |
Synopsis Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae? by : Kulmira Nurgali
Advances in anti-cancer chemotherapy over recent years have led to improved efficacy in curing or controlling many cancers. Some chemotherapy-related side-effects are well recognized and include: nausea, vomiting, bone marrow suppression, peripheral neuropathy, cardiac and skeletal muscle dysfunction and renal impairment. However, it is becoming clearer that some chemotherapy-related adverse effects may persist even in long term cancer survivors. Problems such as cognitive, cardiovascular and gastrointestinal dysfunction, and neuropathy may lead to substantial long term morbidity. Despite improvements in treatments to counteract acute chemotherapy-induced adverse effects, they are often incompletely effective. Furthermore, counter-measures for some acute side-effects and many potential longer term sequelae of anti-cancer chemotherapy have not been developed. Thus, new insights into prevalence and mechanisms of cancer chemotherapy-related side effects are needed and new approaches to improving tolerance and reduce sequelae of cancer chemotherapy are urgently needed. The present Research Topic focuses on adverse effects and sequelae of chemotherapy and strategies to counteract them.